Measles Vaccination Cash Incentives Experimental Evidence From Nigeria

IDinsight is conducting a randomized controlled trial to assess the impact of various sized cash incentives for caretakers of infants that require a 9-month measles vaccination on the completion rate for the vaccine in Nigeria. The purpose of the experiment is to help New Incentives (NI) determine the optimal size of the incentive as they scale to the North West region of Nigeria.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Measles Infections Mononegavirales Infections Morbillivirus Infections Paramyxoviridae Infections RNA Virus Infections Virus Diseases

Age range

9 month and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

All Babies are Equal Initiative (New Incentives)

Abuja, Federal Capital Territory, Nigeria

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Caregiver and infant registered with the New Incentives program
The infant was nine months or older at the start of the study (note there was no upper age limit as New Incentives only began enrolling infants in October 2016)
Infant had received at least one previous conditional cash transfer for immunization at an All Babies are Equal Initiative clinic,
Infant had received their Penta-3 vaccine.
The caregiver had provided a phone number (either a personal number or a number of someone who can reach them) during registration.

Exclusion criteria

Infant had already received a measles vaccine

Treatment and study plan

Cash Incentive

Behavioral

During the phone call, New Incentives' team member promised a greater cash payment from New Incentives' staff members at primary health care facilities when infants enrolled in the program and received their measles vaccination.

Call

Behavioral

A New Incentives' team member reminded caregivers of their child's measles immunization date and the total amount of incentive they would receive once their child was vaccinated. If the caregiver could not be reached on the first attempt, the team made additional attempts at different times of the day on five different days across two weeks (up to 10 attempts were made per caregiver).

Primary outcomes

Measles Vaccination Coverage Rate

Time frame: We assessed whether eligible infants received measles vaccination at any time during the 4 month study period. Children were a minimum of 9 months at the beginning of the study and a maximum of 7 years at the end of the study.

The outcome of interest is the measles coverage rate among the eligible randomized infants. Coverage is measured using the measles vaccination information recorded on the child's health card. The child health card information was immediately entered into the New Incentives' database by their field staff when they disbursed the cash incentives at program clinics. Information from the New Incentives' database was used for the analysis.

Sponsors and collaborators

Lead sponsor

IDinsight

Other

Collaborators

GiveWell

Registry information

Important dates

Study start: 2017
Primary completion: 2017
Study completion: 2017
First posted: Jul 9, 2019
Registry last updated: Jul 9, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed